Heart transplant in Turkey

Türkiye became a major destination for organ transplantation for a specific reason: it built enormous expertise in living-donor surgery. Because its deceased donation rate is low, Turkish surgeons developed living-donor kidney and liver programmes at a scale few countries match, and international patients who can bring a related donor travel there in significant numbers.

That model does not extend to hearts, and cannot. A living-donor programme depends on there being a donor who survives donation. For kidneys the donor keeps one; for livers the remaining lobe regenerates. A heart has no such arrangement, so every heart transplanted anywhere comes from somebody who has died.

This produces a situation that confuses many families. They read that Türkiye is a leading transplant destination — which is true — and reasonably assume that applies to all transplants. It does not. The strength of the Turkish programmes and the openness of the Turkish pathway are both consequences of living donation, and neither transfers to a procedure where living donation is impossible.

The practical picture inside Türkiye is a national waiting list under pressure, served by a coordination system that distributes a scarce supply of deceased-donor organs among people registered within it. Adding international patients to that list is not a policy choice hospitals are free to make.

What Turkish cardiac centres do offer international patients is substantial, and it is not a consolation prize. High-volume cardiac surgery units perform coronary bypass, valve repair and replacement, aortic surgery, congenital correction and arrhythmia ablation for patients from across the region. Several centres implant mechanical circulatory support. For somebody with advanced heart failure who cannot be transplanted at home either, a device assessment is a real and sometimes decisive option.

This page therefore does something unusual for a destination page: it spends most of its length explaining why the headline procedure is unavailable, and the rest on what is genuinely worth travelling for.

It helps to separate three questions that get collapsed into one: whether you need a transplant, whether you could have one in Türkiye, and whether there is something else Turkish medicine can do for you.

On the second question the answer has already been given, and it does not depend on how sick you are or how much you can pay. The barrier is structural: there is no organ to allocate to you.

On the third question the answer is more encouraging, and it is worth working through properly. If your heart failure has not been fully assessed, a second opinion from a Turkish heart failure team is straightforwardly available. Records, echocardiograms, catheterisation results and imaging can be reviewed remotely before anybody travels, and that review alone sometimes changes the plan — occasionally by finding treatable disease that was missed.

If your failure is advanced and transplantation is not open to you anywhere, mechanical circulatory support becomes the question that matters. A durable left ventricular assist device is an operation and a device rather than an organ, so it can in principle be provided to an international patient by a centre with a programme. That is a genuine avenue, but it comes with a hard condition: a device needs lifelong management, anticoagulation monitoring, driveline care and emergency access. Having one implanted in a country you will then leave is only sensible if somebody at home can look after it, and establishing that must come before any decision to travel.

If the underlying problem is coronary disease, valve disease or a congenital defect, the position is much simpler. These are treated surgically on your own heart, are performed at high volume in Türkiye, and involve no organ allocation whatsoever. A number of people who arrive believing they need a transplant turn out to need one of these instead, which is the strongest argument for a proper assessment before assuming the worst.

And if you are already listed for transplantation in your own country, the most valuable advice is usually to stay listed. Time accrued on a list is not portable, and leaving to pursue an option abroad can cost a place that took years to reach.

If you are pursuing a second opinion or a device assessment rather than a transplant, the review starts with documents. What a Turkish heart failure team needs is much the same as any other team would want, and sending it properly is the difference between a useful answer in days and a vague one in weeks.

Send the echocardiogram reports with their measurements, not just the conclusions, and the images themselves where possible. Send any cardiac catheterisation report, particularly a right heart study with pulmonary pressures and resistance, because that single measurement shapes what is possible. Send cardiac MRI or CT if performed, along with rhythm monitoring, device interrogation reports if you have a pacemaker or defibrillator, and a clear list of current medications with doses.

Send the history in plain chronological order: when the diagnosis was made, what has been tried, what happened each time, and how many hospital admissions there have been. A summary letter from your own cardiologist is worth more than a folder of unsorted results.

Blood tests matter more than people expect, because kidney and liver function reveal how far poor circulation has affected other organs, and that changes both the assessment and the options.

Have everything translated into English or Turkish before sending. Untranslated records are the commonest reason a review stalls, and translation is cheaper than a wasted trip.

If a device is being considered, expect the team to want a formal assessment of exercise capacity, a right heart catheterisation performed recently, and a frank discussion about who will manage the device afterwards. A centre that does not raise that last point has not thought the case through.

Hospitals recorded on this platform are taken from public references rather than marketing claims, and a hospital appearing here does not indicate that it can transplant a heart into an international patient — none can. What these centres can be asked about is device therapy, conventional cardiac surgery, and second opinions. The questions that separate a serious unit from a sales department are how many of your specific operation they perform each year, what their results are in cases like yours, and who will manage your care after you go home.

Names shown are linked to their current recorded hospital affiliations and update when those change. Inclusion records an affiliation; it is not a personal recommendation, and the choice of clinician is between you and the centre after your records have been read.

Because a transplant is not on the table, the realistic stay to plan for is one of the operations that is. These are shorter and more predictable than a transplant, but they are still major cardiac surgery and the timeline deserves respect.

For conventional cardiac surgery — bypass, valve, congenital repair — expect a few days of assessment on arrival, the operation, several days in intensive care and a step-down ward, and then a period before you are cleared to fly. Two to three weeks in the country is a realistic plan for an uncomplicated course, and flying too early after chest surgery is a genuine risk rather than an inconvenience.

For implantation of a durable assist device the stay is longer and the education more demanding. Beyond recovery from the operation, you and whoever cares for you must be trained to manage the equipment: changing batteries, caring for the driveline exit site, recognising alarms, and managing anticoagulation. Programmes will not discharge somebody who has not demonstrated that competence, and they are right not to. Plan for several weeks rather than several days.

The sternum takes six to twelve weeks to heal in either case, which governs lifting, driving and activity long after you have flown home. Cardiac rehabilitation should be arranged at home before you leave, not sought afterwards.

One consideration is specific to travelling for device therapy and should be settled first. An assist device requires monitoring for the rest of its use, and complications are managed urgently rather than at the next appointment. If your home country has no centre able to manage the device you are considering, that is not a detail to resolve later — it is a reason to reconsider the plan.

If you are travelling to Türkiye for cardiac surgery or a device rather than a transplant, the logistics are those of major surgery abroad and are manageable with planning.

Visa requirements vary considerably by nationality: some travellers enter without a prior visa, others need an electronic authorisation, and others require a consular appointment that can take weeks. Start that process in parallel with the medical review rather than after it, and ask the hospital for an invitation letter stating the purpose and expected duration.

Ask your own cardiologist explicitly whether you are fit to fly before booking. Advanced heart failure can make commercial flight risky, and some patients need supplemental oxygen or a medical escort. This is a clinical question, not a travel one, and it should be answered before tickets are bought.

Plan for a companion, and for longer than you expect. Accommodation near the hospital matters because follow-up visits are frequent, and a kitchen is worth having when a cardiac diet is involved. Book somewhere that can be extended: a complication turning a two-week stay into a five-week one is the scenario that ruins budgets.

Carry medication in hand luggage in original packaging, with a letter listing everything and its doses, and bring more than the planned trip requires. Bring original imaging on disc as well as reports, because a Turkish team may want to review the images themselves.

On payment, ask which currency the contract is written in, what the schedule is, what the daily rate is for extra intensive care and ward days, and what is refundable if surgery is cancelled for medical reasons. Transfer to the hospital's official account named in the contract — never to an individual's account, however trustworthy the intermediary seems — and get a receipt for every payment.

Finally, arrange the return before you go: who reviews you at home, when, and what happens if something goes wrong at 2am in your own city. For device patients this is not paperwork; it is the difference between a device that is manageable and one that is dangerous.

The clinical risks of cardiac surgery and device implantation are set out on the procedure pages this one links to. What belongs here are the risks created by doing it far from home.

The first is discontinuity. Cardiac surgery and devices both need follow-up, and a complication that arises after you have flown home is managed by people who did not perform the operation and may not have the records. Insist on a detailed operative note and discharge summary in a language your own doctors read, and make sure a named clinician at home has accepted your care before you travel.

The second is the pressure of a sunk cost. Families who have travelled a long way and spent a great deal are more likely to accept a plan they would have questioned at home. If a Turkish team recommends something different from what you came for, that may well be right — but it should be a decision made calmly, with a second opinion if you want one, not under the weight of what the trip has already cost.

The third is fraud, and it is the reason much of this page exists. Anybody promising a heart transplant in Türkiye to a foreign patient is either uninformed or exploiting you, and the money involved is usually unrecoverable. The pattern is consistent: an assurance by phone or messaging, a request for a substantial payment before any doctor has read the records, and a refusal to put anything in writing.

The fourth is delay. Time spent pursuing an option that does not exist is time not spent on options that do, including staying listed at home, being assessed for a device, or having the underlying disease treated. For somebody with advanced heart failure, that lost time has a clinical cost.

None of this argues against travelling for cardiac care in Türkiye, which many people do successfully. It argues for travelling for the right thing, with the right paperwork, having verified what you were told.